Teva gets FDA OK for rare disease treatment

The Food and Drug Administration approved Austedo, a drug developed by Teva Pharmaceutical Industries Ltd. to treat chorea associated with Huntington ’s disease. Huntington’s disease is a rare and fatal neurodegenerative disorder that affects more than 35,000 people in the United States. Chorea, a condition characterized by involuntary, random and sudden, twisting and/or writhing movements, is a physical manifestation of the disease that occ urs in about 90 percent of Huntingdon’s disease patients. “Chorea…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news